key: cord-0257035-h1jb47pj
authors: Gorji, H.; Lunati, I.; Rudolf, F.; Vidondo, B.; Hardt, W.-D.; Jenny, P.; Engel, D.; Schneider, J.; Jamnicki, M.; Leuthold, R.; Risch, L.; Risch, M.; Bühler, M.; Sommer, A.; Caduff, A.
title: Results from Canton Grisons of Switzerland Suggest Repetitive Testing Reduces SARS-CoV-2 Incidence (February-March 2021)
date: 2021-07-16
journal: nan
DOI: 10.1101/2021.07.13.21259739
sha: e894af43586e985ee22e8b1981746923cacf3b11
doc_id: 257035
cord_uid: h1jb47pj

In February 2021, in response to emergence of more transmissible SARS-CoV-2 virus variants, the Canton Grisons launched a unique RNA mass testing program targeting the labour force in local businesses. Employees were offered weekly tests free of charge and on a voluntary basis. If tested positive, they were required to self-isolate for ten days and their contacts were subjected to daily testing at work. Thereby, the quarantine of contact persons could be waved. Here, we evaluate the effects of the testing program on the tested cohorts. We examined 121'364 test results from 27'514 participants during February-March 2021. By distinguishing different cohorts of employees, we observe a noticeable decrease in the test positivity rate and a statistically significant reduction in the associated incidence rate over the considered period. The reduction in the latter ranges between 18%-50%. The variability is partly explained by different exposures to exogenous infection sources (e.g., contacts with visiting tourists or cross-border commuters). Our analysis provides the first empirical evidence that applying repetitive mass testing to a real population over an extended period of time can prevent spread of COVID-19 pandemic. However, to overcome logistic, uptake, and adherence challenges it is important that the program is carefully designed and that disease incursion from the population outside of the program is considered and controlled.

State of knowledge in mass testing 25 Repetitive testing of people without noticeable symptoms has been proposed as a public health 26 measure in response to COVID-19 pandemic. The concept relies on reducing the effective in-27 fectiousness period by isolating the positively tested individuals when they are presymptomatic 28 or asymptomatic. Theoretical studies have demonstrated that repetitive mass testing helps con-29 consecutive days. As long as they remain negative, they are allowed to continue to work on company's premises with few restrictions (e.g. wearing mask and minimizing contacts when 85 possible): they are asked to self-isolate only if their own test result is positive. This "test-and- 86 release" protocol minimizes the number of people in quarantine and thereby limits possible 87 burdens on the participating businesses. In addition, external contacts (e.g., family and friends) 88 of the infected employee are informed to take precautionary measures and test according to 89 the associated contact tracing program. Even though they are not included in the mass testing 90 program, their risk of infection will be reduced by having a part of their contact network (the 91 employees enrolled in the mass testing program) regularly tested and a beneficial secondary 92 effect is expected for the general canton's population. 

Quantifying the effect of such a repetitive mass testing program in businesses in a real-time 109 setting is not straightforward. For these reasons, instead of focusing on population-based epidemiological quantities in the 126 Canton, here we limit ourselves to a finer-grain analysis: we evaluate the impact of testing 127 on the evolution of the epidemics among participants. Therefore, we consider two groups of 128 employees: the first group consists of the newly enrolled ones, the second group of the ones 129 who have been enrolled in the program for a longer time and have therefore been tested repeat-count for the influence of different epidemiological conditions at the time of enrollment, which change over time, we divided the repeatedly tested employees into different cohorts according 134 to the week during which they joined the program (i.e., we define week 1, week 2, and week 135 3 cohorts) (see Supplemenraty materials, Cohort definition ). Here, we analyze the first two 136 months of this program until the Easter break period, for which the data is already consolidated.

Test positivity rate and incidence rate ratio 139 To infer the epidemiological changes among tested employees, we compute two complemen-140 tary quantities: test positivity rate (TPR) and incidence rate ratio. The seven-day average TPR 141 is calculated as the proportion of new positive cases to the total number of RT-PCR tests per 142 seven days. Figure 1 shows the Loess fit of the seven-day average TPR for the newly enrolled conditions for the different tested cohorts. Especially, the initial TPR value of the week 3 cohort 150 is twice as high as the one corresponding to the week 1 cohort. Even though TPR was lower 151 during enrollment of the week 1 cohort, this cohort shows a remarkably smaller and more un-152 certain reduction in TPR than the other two cohorts joining in later weeks.

The reduction of TPR over the period in which the cohort is repeatedly tested varies from 155 73% (over 7 weeks) to 56% (over 6 weeks), for week 2 and week 3 cohorts, respectively. The 156 7 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 16, 2021.

week 1 cohort shows a 44% increase over the entire eight-week period. Notice that during the same eight-week period, TPR of the newly enrolled population almost doubles (reaching a peak 158 of 0.28% in the fourth week of the program). In general, all three repeatedly tested cohorts of 159 employees exhibit evident reductions in TPR when compared to the newly enrolled population.

Yet given the relatively important uncertainty resulting from our small sample size, the critical 161 question is if the reductions in TPR translate into a statistically significant drop in the incidence 162 rate of the tested cohorts. As an integral measure of the reduction in the number of infections over the entire period, 165 we calculate the incidence rate associated with the seven-day average TPR by normalizing the by mid-p exact method, correspond to the test that the incidence rate in the considered cohort 170 has a lower value than the one in the newly enrolled population, hence testing is effective in 171 reducing the number of infections. The estimated reduction in the incidence rate is 18% (95% 172 CI: 0-47%) for the week 1 cohort, 47% (95% CI: 5-71%) for the week 2 cohort and 50% (95% 173 CI: 4-76%) for the week 3 cohort. For the week 2 and week 3 cohorts, we find a statistically 174 significant reduction of the incidence rate achieved by repetitive testing (p-values 0.03 and 0.04, 175 respectively).

The milder reduction in TPR and incidence rate of the week 1 cohort can partly be explained is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 16, 2021. ; https://doi.org/10.1101/2021.07.13.21259739 doi: medRxiv preprint . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. 

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. 

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. near-border municipalities have been excluded. The reevaluated reduction in the incidence rate 221 almost doubles from 18% to 34% for week 1 cohort, and increases from 48% to 51% for week 222 2 cohort, and from 43% to 61% for week 3 cohort (see Table 4 and Supplementary material, 223 Effect of tourism and cross border commuters for the details). This results in a considerable uncertainty in our analysis. Nevertheless the reduction in the 233 incidence rate that we observed is statistically significant, especially among the groups of em-234 ployees with lower exposure to exogenous disease incursions (e.g., individuals not employed in 235 the tourism sector nor living in touristic/peripheral regions). This is encouraging as it shows that 236 intensifying repetitive testing can be a viable complement to the existing non-pharmaceutical 237 intervention strategies to reach epidemic control. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. ; https://doi.org/10.1101/2021.07.13.21259739 doi: medRxiv preprint

To define the objectives and plan a successful repetitive testing concept, it is important to care-250 fully consider the interaction within and between the tested and untested sub-populations, as 251 their dynamic is far from being homogeneous. On the one hand, the repeatedly tested indi-252 viduals actively contribute to curb the virus spread: as the tested cohort itself benefits from a 253 reduced incidence, their untested contacts are also exposed to a lower risk of infection. On CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. ; https://doi.org/10.1101/2021.07.13.21259739 doi: medRxiv preprint sorting to repetitive mass testing programs remains certainly valuable, for instance, in societal 274 branches for which vaccination isn't possible yet or in which outbreaks due to exposure to new 275 mutants is highly probable (e.g. at schools or in the tourism sector). This requires a coordinated 276 engagement of policy makers, communities and the public to adopt carefully designed testing 277 programs that could be sustained over an extended period of time. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. 

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. 

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. ;

Positively identified individuals are asked to self-isolate for ten days. The quarantine of the work contacts of the positive cases is waved and replaced by daily testing for maximum of ten Cohort definition 371 We define the following sub-populations of test results. hasn't been previously tested in our testing campaign, and if the company site has not 374 been in the program for more than two weeks prior to the test date. The latter condition is 375 introduced to exclude (to some extent) the effect of community protection due to testing, 376 which might occur among those employees of a company that have started to participate 377 later. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. ; https://doi.org/10.1101/2021.07.13.21259739 doi: medRxiv preprint week 1, week 2, and week 3 cohorts. During its first seven days each cohort coincides 381 with the newly enrolled population. We only count an individual in the cohort if at least 382 5 persons from the same company site participate consistently (i.e., they are tested every 383 week). In other words, we only keep those individuals in the cohort, whose companies 384 sites remain active in the program. Notice that the results are robust with respect to the 385 adopted minimum number of active participants per company site, henceforth called "unit 386 cohort size" (illustrated in Tables 2 and 3 ). 387 Figure 3 shows the geographical distribution of the work places of newly enrolled employees.

The share of touristic and near-border regions is noticeably higher in the week 1 cohort than in 389 the cohorts of the two subsequent weeks. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. ; https://doi.org/10.1101/2021.07.13.21259739 doi: medRxiv preprint Therefore the seven-day-average TPR is given by TPR(τ ) =Ī(τ )/N (τ ). The histograms 405 in Fig. 4 (A) , (B) and (C) show the resulting TPR for newly enrolled employees side by 406 side with the week 1,2 and 3 cohorts, respectively. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. ; adopted incidence rate is an approximation of the area below the TPR curve (normalized by time). In order to avoid complications in our incidence rate estimations, we assume 431 unity sensitivity and specificity of the tests. Furthermore, the time lag between infection 432 and detection via the test is neglected. By binning the data of each cohort into weeks, we 433 estimate the incidence rate of cohort 1 from week 2 till 8, cohort 2 from week 3 till 8, and 434 cohort 3 from week 4 till 8. The incidence rates are compared with the incidence rate of Consider IR j c to be the incidence rate for the repeatedly tested cohort that joins the pro- dence rate for a cohort that starts at week j is

Accordingly, for the newly enrolled incidence rate IR 0 we have

where N 0 (i) and I 0 (i) are the number of tested people and discovered positive cases, 443 respectively, at week i among the newly enrolled population. In order to compare the in-444 cidence rate of each cohort with the newly enrolled population for a similar time interval, using mid-p exact method (20, 21). The results are provided in Table 1 . Furthermore, we repeat the evaluation of the incidence rate ratio by changing the minimum number 451 of consistent participants per company site. The results are given in Table 2 for unit 452 cohort size of 3, and in Table 3 for unit cohort size of 7. While the estimates do not vary 453 much with respect to the unit cohort size, we observe that larger unit cohort sizes tend to 454 correlate with smaller incidence rate ratios, and thus stronger reduction in the incidence 455 rate. For example in the week 1 cohort, we find that the reduction increases from 16% to 456 26%, once the unit cohort size grows from 3 to 7. This is in line with the expectation that 457 more effective reduction in the incidence rate would be achieved in companies, where 458 larger pools of employees participate in the program.

To better understand the disparity in TPR and incidence rate reduction of different cohorts, we Fig. 1) , removing a large portion of the data can be misleading. It may be 470 more appropriate to take into account tourist-related infections by performing a regional anal-471 ysis of the data rather than separating the different business sectors. Therefore, we decided to 472 exclude a few touristic and near-border municipalities from the data set.

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 16, 2021. ; https://doi.org/10.1101/2021.07.13.21259739 doi: medRxiv preprint represented in the week 1 cohort than in the other two. In the filtered data set we observe that 478 the share of tourism sector is shrank from 43% to 34% in week 1 cohort, from 27% to 26% in 479 week 2 cohort, and from 23% to 22% in week 3 cohort. The incidence rate ratio of each cohort 480 with respect to the newly enrolled one is re-evaluated and reported in 

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 16, 2021. ; https://doi.org/10.1101/2021.07.13.21259739 doi: medRxiv preprint

The Lancet Infectious Diseases

Covid-19: People are not being warned about pitfalls of mass testing